Lymphocyte infiltration predicts survival in chemotherapy-naive, triple-negative breast cancer and identifies patients with intrinsically good prognosis: Have we been bringing owls to Athens? Editorial

  

Authors:	Dubsky, P.; Montagna, G.; Ritter, M.
Title:	Lymphocyte infiltration predicts survival in chemotherapy-naive, triple-negative breast cancer and identifies patients with intrinsically good prognosis: Have we been bringing owls to Athens?
Keywords:	cancer survival; cytotoxic agent; disease marker; cancer adjuvant therapy; cancer patient; preoperative care; neoadjuvant therapy; nuclear magnetic resonance imaging; antineoplastic agent; t lymphocyte; cancer immunotherapy; editorial; practice guideline; prediction; patient identification; taxane derivative; lymphocytic infiltration; anthracycline; memory t lymphocyte; molecular diagnosis; tumor immunology; triple negative breast cancer; clinical outcome; cancer prognosis; human; priority journal
Journal Title:	Annals of Oncology
Volume:	30
Issue:	12
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2019-12-01
Start Page:	1849
End Page:	1850
Language:	English
DOI:	10.1093/annonc/mdz444
PUBMED:	31626275
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077403925&doi=10.1093%2fannonc%2fmdz444&partnerID=40&md5=72d0a53024d47b47c386112566aaa20e
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/159769